By Devin Partida – Traditional quality assurance depends on paper-based workflows, which are prone to human error and inefficiencies. The rise of data sharing and analysis in drug discovery, diagnostics, medical device manufacturing and pharmaceutical supply chains demands change.
Read More
In this monthly report you will find news and highlights in the Applied Life Sciences from CMS, OFD Life Sciences, Perceptive eClinical, iPerf, Relaxera, BIOTRONIK, Verana Health, Matricelf, Touchlight, neuroClues, BSM Biotech, Neurizon Therapeutics Limited, Biotium, Quintessence Biotech, Kupando, and more.
By Houda Hachad – Cancer care is undergoing a structural transformation. Advances in early detection, targeted therapies, and immunotherapies have improved outcomes. According to the American Cancer Society, the five-year survival rate for all cancers combined has now reached 70%, reflecting meaningful progress in treatment and care delivery.
By Daniel Caños PhD MPH & Michelle Tarver MD PhD – Today’s health care ecosystem is generating richer and more diverse data streams, providing new opportunities to modernize how Real-World Data generates relevant and reliable Real-World Evidence. The FDA is working to provide clearer recommendations and more consistent acceptance of RWE as valid scientific evidence.
In this monthly report you will find news and highlights in the Applied Life Sciences from BioMed X, ConcertAI, UCSF, Michigan Integrative Health Stem Cells, Kandu, Biotium, PhaseV, Freudenberg Medical, Vetter, MetP Pharma AG, Hemex Health, ONWARD Medical and more.
In this monthly report you will find news and highlights in the Applied Life Sciences from BioMed X, ConcertAI, UCSF, Michigan Integrative Health Stem Cells, Kandu, Biotium, PhaseV, Freudenberg Medical, Vetter, MetP Pharma AG, Hemex Health, ONWARD Medical and more.
Latest News and grants from The Advanced Research Projects Agency for Health (ARPA-H). This HHS agency’s mission is to fund pivotal, high‑risk/high‑reward technologies that traditional research or commercial pathways struggle to deliver—mirroring the DARPA model but focused on health.
Our annual predictions for 2026 continue with Life Science. Throughout the next few weeks we will be asking the industry experts what they think we will see in 2026. Check back as we cover AI in healthcare, interoperability, patient experience. Value-Based Care, and the business of healthcare.
By Karin Hayes – Pharma marketing is evolving beyond traditional, one-size-fits-all approaches toward more personalized, data-driven engagement that truly connects with today’s consumers. Data now fuels smarter engagement, empowering patients to take a more active role in their care, giving providers deeper insight into treatment decisions, and ultimately improving outcomes.